Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
'Pharma bro' Martin Shkreli settles all cases with Retrophin weeks after suing drug company's direct
Source: CNBC
‘Pharma bro’ Martin Shkreli settles all cases with Retrophin weeks after suing drug company’s directors from prison
PUBLISHED THU, JUN 20 2019 12:26 PM EDT UPDATED THU, JUN 20 2019 2:27 PM EDT
Dan Mangan
Notorious “pharma bro” Martin Shkreli has reached a settlement that “covers all outstanding disputes” with his former biopharmaceutical company Retrophin just weeks after he sued two company directors and its ex-general counsel from prison, Retrophin said Thursday.
Terms of the settlement were not disclosed. But Retrophin issued a statement to CNBC on Thursday when asked about Shkreli having filed a notice to dismiss on Tuesday of his recent lawsuit alleging fraud by the directors and ex-counsel.
“Retrophin and Martin Shkreli have reached a settlement resolving all outstanding disputes between them,” a Retrophin spokeswoman said.
“We are pleased with this outcome and remain focused on delivering life-changing therapies to people living with rare diseases. Additional information about the settlement will be provided in Retrophin’s forthcoming quarterly filing.”
-snip-
PUBLISHED THU, JUN 20 2019 12:26 PM EDT UPDATED THU, JUN 20 2019 2:27 PM EDT
Dan Mangan
Notorious “pharma bro” Martin Shkreli has reached a settlement that “covers all outstanding disputes” with his former biopharmaceutical company Retrophin just weeks after he sued two company directors and its ex-general counsel from prison, Retrophin said Thursday.
Terms of the settlement were not disclosed. But Retrophin issued a statement to CNBC on Thursday when asked about Shkreli having filed a notice to dismiss on Tuesday of his recent lawsuit alleging fraud by the directors and ex-counsel.
“Retrophin and Martin Shkreli have reached a settlement resolving all outstanding disputes between them,” a Retrophin spokeswoman said.
“We are pleased with this outcome and remain focused on delivering life-changing therapies to people living with rare diseases. Additional information about the settlement will be provided in Retrophin’s forthcoming quarterly filing.”
-snip-
Read more: https://www.cnbc.com/2019/06/20/pharma-bro-martin-shkreli-settles-case-with-retrophin.html
